Key Dates
|
Symposium dates: 2nd & 3rd November 2023
Early bird registration closes: 22 September 2023 Full registration registration closes: 26 October 2023 |
#TAS2023
|
Welcome
On behalf of the organizing committee we are excited to announce the 9th Thomas Ashworth CTC & Liquid Biopsy Symposium will be held as an in-person event at Peter MacCallum Cancer Centre, Melbourne on the 2nd and 3rd November 2023. The registration desk and the spacious well-designed symposium lecture hall is located on 7th floor. We hope the setting will inspire both speakers and delegates to engage enthusiastically to advance liquid biopsy research its clinical implementation.
The Symposium will run over 2 days enabling us to cover cutting-edge advances in liquid biopsy translational research and clinical applications. The program will begin at 9am on Thursday 2nd November and close at 5pm on Friday3rd November.
The aim of the Symposium is to enrich our understanding of the clinical application of liquid biopsy and improve patient outcomes, as well as provide critical insights into the metastatic process and application of liquid biopsy in different contexts. Topics that will be explored include circulating tumour cells, exosomes, methylated ctDNA, assay development, early detection, integration of liquid biopsy into clinical trials and precision oncology, treatment selection and monitoring as well as drug resistance monitoring.
An exciting line up of invited keynote speakers who are leaders in the field will be showcasing their liquid biopsy research. In addition, invited speakers and speakers selected from submitted abstracts from across Australia, New Zealand and Asia will present their latest research. Two panel discussions are included in the program and are designed to highlight patient perspectives and health professional views with the intent to stimulate debate and are a symposium highlight.
The Symposium will run over 2 days enabling us to cover cutting-edge advances in liquid biopsy translational research and clinical applications. The program will begin at 9am on Thursday 2nd November and close at 5pm on Friday3rd November.
The aim of the Symposium is to enrich our understanding of the clinical application of liquid biopsy and improve patient outcomes, as well as provide critical insights into the metastatic process and application of liquid biopsy in different contexts. Topics that will be explored include circulating tumour cells, exosomes, methylated ctDNA, assay development, early detection, integration of liquid biopsy into clinical trials and precision oncology, treatment selection and monitoring as well as drug resistance monitoring.
An exciting line up of invited keynote speakers who are leaders in the field will be showcasing their liquid biopsy research. In addition, invited speakers and speakers selected from submitted abstracts from across Australia, New Zealand and Asia will present their latest research. Two panel discussions are included in the program and are designed to highlight patient perspectives and health professional views with the intent to stimulate debate and are a symposium highlight.
Confirmed Keynote Speakers
Professor Razelle Kurzrock MD
Professor of Medicine, Associate Director, Clinical Research
Linda T. And John A. Mellowes Chair of Precision Oncology, MCW Cancer Center and
Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine
Founding Director, Michels Rare Cancers Research Laboratories
Froedtert and Medical College of Wisconsin
Chief Medical Officer, Worldwide Innovative Network (WIN) for Personalized Cancer Therapy, USA
Professor Jonathan Karpelowsky MBBCh. FCS. Cert Paed Surg. FRACS. PhD
Professor of Paediatric Surgery Division of Child and Adolescent Health Children's Hospital Westmead, Australia
A/Professor Anders Skanderup
Genome Institute of Singapore, A*STAR, Singapore
Genome Institute of Singapore, A*STAR, Singapore
SUBMIT AN ABSTRACT The opportunity to submit abstracts for oral and poster presentations is available. All abstracts will be reviewed by a panel and those chosen for oral presentation will be notified prior to the Symposium. Submissions are welcome from all delegates. For young investigators generous prizes will be awarded to rapid fire oral presentation finalists and the best poster - the abstract submission deadline is Friday 23th September 5pm.
Accommodation options and link to discounted room rates at the Larwill are on the Destination page.
Who should attend?
- Translational/clinical researchers
- Medical oncologists
- Pathologists
- Patient advocates
- Clinical trainees, PhD and other students
- Pharmaceutical and diagnostic sector
The organising committee maintains a philosophy of keeping registration costs as low as possible to encourage attendance and this is only possible through the generous support of our sponsors. So please ensure to visit the exhibitor tables and check out their latest product offerings.
We look forward to seeing you at the Symposium in October.
|
|
Dr Stephen Wong and Associate Professor Kevin Spring
C0-convenors, 9th Thomas Ashworth CTC & Liquid Biopsy Symposium
C0-convenors, 9th Thomas Ashworth CTC & Liquid Biopsy Symposium
Platinum Sponsors
|
|
|
|
|
Gold Sponsors
|
|
Organizing Committee
A/Prof. Kevin Spring ( Convenor), Ingham Institute, Western Sydney University, Sydney
A/Prof. Therese Becker, Ingham Institute, Sydney
A/Prof. Mark Cowley, Children's Cancer Institute, Sydney
A/Prof. Alex Dobrovic, University of Melbourne, Melbourne
A/Prof. Elin Gray, Edith Cowen University, Perth
Dr. Stephen Wong, Peter MacCallum Cancer Centre, Melbourne
A/Prof. Craig Gedye, Calvary Mater Newcastle & Hunter Medical Research Institute, University of Newcastle, Newcastle
Prof. Chamindie Punyadeera, Griffith University, Brisbane
Prof. Rik Thompson, QUT, Brisbane
Dr Kristina Warton, UNSW, Sydney
Dr Dineika Chandrananda Dineika, Peter MacCallum Cancer Centre, Melbourne
Dr Heidi Fettke,. Peter MacCallum Cancer Centre, Melbourne
For more information please contact Dr Stephen Wong - Stephen.Wong@petermac.org or A/Prof Kevin Spring - k.spring@westernsydney.edu.au
A/Prof. Kevin Spring ( Convenor), Ingham Institute, Western Sydney University, Sydney
A/Prof. Therese Becker, Ingham Institute, Sydney
A/Prof. Mark Cowley, Children's Cancer Institute, Sydney
A/Prof. Alex Dobrovic, University of Melbourne, Melbourne
A/Prof. Elin Gray, Edith Cowen University, Perth
Dr. Stephen Wong, Peter MacCallum Cancer Centre, Melbourne
A/Prof. Craig Gedye, Calvary Mater Newcastle & Hunter Medical Research Institute, University of Newcastle, Newcastle
Prof. Chamindie Punyadeera, Griffith University, Brisbane
Prof. Rik Thompson, QUT, Brisbane
Dr Kristina Warton, UNSW, Sydney
Dr Dineika Chandrananda Dineika, Peter MacCallum Cancer Centre, Melbourne
Dr Heidi Fettke,. Peter MacCallum Cancer Centre, Melbourne
For more information please contact Dr Stephen Wong - Stephen.Wong@petermac.org or A/Prof Kevin Spring - k.spring@westernsydney.edu.au
Copyright 2023 ThomasAshworthSymposium